Back to Trials
NCT06029075NARecruiting

tACS for Neuropathic Pain Management After SCI

The University of Texas Health Science Center, Houston

Start Date

9/1/2025

Completion Date

3/31/2028

Summary

The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for neuropathic pain management in people after spinal cord injury.

Eligibility Criteria

Age Range: 18 years to 75 years

Inclusion/exclusion criteria for SCI subjects Inclusion criteria: A patient who 1. has neuropathic pain after traumatic spinal cord injury or amputation or brain injury; 2. has chronic pain, \>3 months; 3. is between 18 to 75 years of age; 4. is stable on oral pain medications at least two weeks. Patients are allowed to continue their pain medications, i.e., no change in pain medications. NOTE: we plan to begin the study with the spinal cord injury (SCI) subject population as a cohort first, then expand to other subject populations Exclusion criteria: Patients will be excluded if they 1. are currently adjusting oral pain medications for their neuropathic pain; 2. have pain, but not neuropathic, e.g., from inflammation at the incision wound of the residual limb or neuroma; 3. have a pacemaker metal implants or supplemental oxygen; 4. have amputation in their arm(s); 5. fail to have a motor contraction in the arm muscles with TMS; 6. are not able to follow commands, or to give consent; 7. have asthma or other pulmonary disease; 8. are not medically stable; 9. have preexisting psychiatric disorders; 10. alcohol or drug abuse.

Interventions

DEVICE

tACS Sham

DEVICE

tACS 10Hz

DEVICE

tACS 20Hz

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Neuropathic Pain Management

Locations

The University of Texas Health Science Center

Houston, Texas 77030

United States